These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 31949743)

  • 21. Associations of MACC1, AGR2, and KAI1 expression with the metastasis and prognosis in head and neck squamous cell carcinoma.
    Sun B; Cheng Z; Sun J
    Int J Clin Exp Pathol; 2018; 11(2):822-830. PubMed ID: 31938171
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Correlation between aneuploidy of chromosome 17, over-expression of TP53 and TOPIIalpha, and the clinicopathological features and diagnosis of gastric adenocarcinoma].
    Lu HZ; Wu YP; Luo W; Han YL; Cai Y; Xu X; Liang J; Liu SM; Wang MR
    Zhonghua Zhong Liu Za Zhi; 2009 Oct; 31(10):754-8. PubMed ID: 20021828
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Expression of breast cancer stem cell markers as predictors of prognosis and response to trastuzumab in HER2-positive breast cancer.
    Seo AN; Lee HJ; Kim EJ; Jang MH; Kim YJ; Kim JH; Kim SW; Ryu HS; Park IA; Im SA; Gong G; Jung KH; Kim HJ; Park SY
    Br J Cancer; 2016 May; 114(10):1109-16. PubMed ID: 27115469
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The expression of aldehyde dehydrogenase 1 in invasive primary breast tumors and axillary lymph node metastases is associated with poor clinical prognosis.
    Dong Y; Bi LR; Xu N; Yang HM; Zhang HT; Ding Y; Shi AP; Fan ZM
    Pathol Res Pract; 2013 Sep; 209(9):555-61. PubMed ID: 23916993
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Musashi-1 Expression is a Prognostic Factor in Ovarian Adenocarcinoma and Correlates with ALDH-1 Expression.
    Chen PX; Li QY; Yang Z
    Pathol Oncol Res; 2015 Sep; 21(4):1133-40. PubMed ID: 25971681
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Overexpression of MTA1 and loss of KAI-1 and KiSS-1 expressions are associated with invasion, metastasis, and poor-prognosis of gallbladder adenocarcinoma.
    Wang W; Yang ZL; Liu JQ; Yang LP; Yang XJ; Fu X
    Tumori; 2014; 100(6):667-74. PubMed ID: 25688501
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Aldehyde dehydrogenase 1 expression is a predictor of poor prognosis in node-positive breast cancers: a long-term follow-up study.
    Yoshioka T; Umekita Y; Ohi Y; Souda M; Sagara Y; Sagara Y; Sagara Y; Rai Y; Tanimoto A
    Histopathology; 2011 Mar; 58(4):608-16. PubMed ID: 21371077
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Expressions of MACC1, Snail, and KISS-1 Proteins in Infiltrating Breast Carcinoma and Its Clinicopathological Features].
    Dong HM; Huang JK; Gong XM; Tao YS
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2016 Sep; 47(5):732-737. PubMed ID: 28598089
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The clinicopathological parameters and prognostic significance of HER2 expression in gastric cancer patients: a meta-analysis of literature.
    Lei YY; Huang JY; Zhao QR; Jiang N; Xu HM; Wang ZN; Li HQ; Zhang SB; Sun Z
    World J Surg Oncol; 2017 Mar; 15(1):68. PubMed ID: 28327158
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Prognostic impact of the cancer stem cell related markers ALDH1 and EZH2 in triple negative and basal-like breast cancers.
    De Brot M; Rocha RM; Soares FA; Gobbi H
    Pathology; 2012 Jun; 44(4):303-12. PubMed ID: 22544210
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Prognosis of gastric adenocarcinoma associated with girdin, Akt, and cortactin.
    Zhang Y; Liu C; Zhou L
    Ann Saudi Med; 2022; 42(3):181-190. PubMed ID: 35770962
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The impact of Aldehyde dehydrogenase 1 expression on prognosis for metastatic colon cancer.
    Fitzgerald TL; Rangan S; Dobbs L; Starr S; Sigounas G
    J Surg Res; 2014 Nov; 192(1):82-9. PubMed ID: 24953984
    [TBL] [Abstract][Full Text] [Related]  

  • 33. IMP3 is a novel biomarker to predict metastasis and prognosis of gastric adenocarcinoma: a retrospective study.
    Wang L; Li HG; Xia ZS; Lü J; Peng TS
    Chin Med J (Engl); 2010 Dec; 123(24):3554-8. PubMed ID: 22166630
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cancer stem cell marker ALDH1 expression is associated with lymph node metastasis and poor survival in esophageal squamous cell carcinoma: a study from high incidence area of northern China.
    Wang Y; Zhe H; Gao P; Zhang N; Li G; Qin J
    Dis Esophagus; 2012 Aug; 25(6):560-5. PubMed ID: 22098156
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Exploring the clonal evolution of CD133/aldehyde-dehydrogenase-1 (ALDH1)-positive cancer stem-like cells from primary to recurrent high-grade serous ovarian cancer (HGSOC). A study of the Ovarian Cancer Therapy-Innovative Models Prolong Survival (OCTIPS) Consortium.
    Ruscito I; Cacsire Castillo-Tong D; Vergote I; Ignat I; Stanske M; Vanderstichele A; Ganapathi RN; Glajzer J; Kulbe H; Trillsch F; Mustea A; Kreuzinger C; Benedetti Panici P; Gourley C; Gabra H; Kessler M; Sehouli J; Darb-Esfahani S; Braicu EI
    Eur J Cancer; 2017 Jul; 79():214-225. PubMed ID: 28525846
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Significance of NQO1 overexpression for prognostic evaluation of gastric adenocarcinoma.
    Lin L; Qin Y; Jin T; Liu S; Zhang S; Shen X; Lin Z
    Exp Mol Pathol; 2014 Apr; 96(2):200-5. PubMed ID: 24384455
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Aldehyde dehydrogenase 1/epidermal growth factor receptor coexpression is characteristic of a highly aggressive, poor-prognosis subgroup of high-grade serous ovarian carcinoma.
    Liebscher CA; Prinzler J; Sinn BV; Budczies J; Denkert C; Noske A; Sehouli J; Braicu EI; Dietel M; Darb-Esfahani S
    Hum Pathol; 2013 Aug; 44(8):1465-71. PubMed ID: 23465277
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Expressions of CD133 and CD44 in gastric adenocarcinoma and their relationship with E-cadherin expression].
    Lu G; Wu X; Zhou L; Yu L; Wu S
    Nan Fang Yi Ke Da Xue Xue Bao; 2013 Nov; 33(11):1632-7. PubMed ID: 24273267
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Mining distinct aldehyde dehydrogenase 1 (ALDH1) isoenzymes in gastric cancer.
    Shen JX; Liu J; Li GW; Huang YT; Wu HT
    Oncotarget; 2016 May; 7(18):25340-9. PubMed ID: 27015121
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The clinical and prognostic impact of aldehyde dehydrogenase 1 in non-small cell lung cancer: a meta-analysis.
    Xue J; Zhao Y; Zou Q; Liang F; Lin F
    Transl Cancer Res; 2020 Mar; 9(3):1914-1925. PubMed ID: 35117538
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.